
India’s much-delayed 2035 climate plan underestimates the country’s clean energy potential and allows for an acceleration of emissions growth, according to analysts. The plan aims to reduce the emissions intensity of its GDP by 47% from 2005 levels and increase the share of its electricity capacity from nonfossil sources to 60% by 2035.
The reduced carbon intensity target would, however, still allow India’s carbon emissions to increase by 70% over the next decade if GDP grows at a target rate of 7% per year, Lauri Myllyvirta of the Centre for Research on Energy and Clean Air told Semafor. That would translate to emissions growth of 5.5% per year, above the average rate of 3.5% over the past decade.
India is also on track to achieve its clean power capacity target well ahead of time: Its Central Electricity Authority projects that nearly 70% of power capacity will come from nonfossil sources by 2035-36.
“India’s booming clean energy industry is highly likely to deliver much faster progress than policymakers were prepared to commit to,” Myllyvirta said. Disruptions to oil and gas flows caused by the Iran war and the competitiveness of clean energy could strengthen the case for accelerating renewable deployment.
LATEST POSTS
- 1
Astronauts' brains change shape and position after time in space, study finds - 2
Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair. - 3
EU Commission prepares €90bn Ukraine loan despite Hungary's veto - 4
A definitive Frozen yogurt Standoff: Which Flavor Rules? - 5
Top German court to rule on claims by Wirecard shareholders
First Alert: Light snow through this evening
Russia’s New KVS Drone May Be Designed To Restore Reach In The FPV War
Cocoa Prices Undercut Amid the Prospects of Abundant Supplies
Overseeing Individual budgets Successfully
Mossad unveils network of Hamas terror infrastructure across Europe
Most loved VR Game for Wellness: Which Keeps You Dynamic?
More parents refusing vitamin K shots for newborns, study finds
Flu cases spiking this holiday season, CDC data shows
Thermo Fisher wins contracts as pharma shifts production to US, CEO says













